FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

18177511000001101: Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 15-Dec 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
62394601000001113 Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
62394701000001115 Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) Is a Risperidone 2mg orodispersible tablets true Inferred relationship Existential restriction modifier
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) Has active ingredient Risperidone true Inferred relationship Existential restriction modifier
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) Has specific active ingredient Risperidone true Inferred relationship Existential restriction modifier
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Orodispersible tablet false Inferred relationship Existential restriction modifier
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) Is a Risperdal Quicklet true Inferred relationship Existential restriction modifier
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) Has dispensed dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) Has manufactured dose form Conventional release orodispersible tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) 28 tablet Has AMP True Risperdal Quicklet 2mg orodispersible tablets (Mawdsley-Brooks & Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start